SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Erin Smith to the newly created position of senior vice president of government affairs and public policy. “With the government and legislative landscape […]
Researchers at University of Pennsylvania Perelman School of Medicine and Charité University Hospitals, Berlin recognized for cutting edge work in autoimmune diseasesTUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced Vinodh Pillai, M.D., Ph.D., Assistant Professor of Pathology and Laboratory Medicine at […]
SAN DIEGO — Exonbio, a leading recombinant antibody CRO company now launches the SARS-CoV-2 Nucleocapsid recombinant monoclonal antibodies for the global IVD and research communities in support of efforts to combat the pandemic. Since the emergence of the COVID-19 outbreak, Exonbio has developed a comprehensive portfolio of SARS-CoV-2 recombinant rabbit antibodies using its proprietary Single Plasma cell INterrogation (SPIN®) platform. […]
ANN ARBOR, Mich. — Swift Biosciences, Inc., a leader in the commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), has signed an agreement to supply its Swift 2S® Turbo DNA Library Kits to Otogenetics Corporation, a high throughput NGS clinical lab offering Prenatal Testing, Deafness Testing, Hereditary Cancer Risk Assessment, clinical exome, […]
CAMBRIDGE, MA – Ultivue, Inc. today announced a collaborative partnership with OracleBio to help further insights and advance personalized tumor characterization in translational and clinical oncology research and drug development using multiplex immunofluorescence staining and imaging. The deal connects the histopathology image analysis expertise of OracleBio and the tissue staining capabilities of Ultivue, with the goal of providing […]
CAMBRIDGE, Mass.– Ultivue, Inc. today announced a collaborative partnership with OracleBio to help further insights and advance personalized tumor characterization in translational and clinical oncology research and drug development using multiplex immunofluorescence staining and imaging. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200722005492/en/ The deal connects the histopathology image analysis expertise of OracleBio and […]
— Includes SARS-CoV-2 Synthetic RNA Control with D614G Mutation — SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the expansion of its infectious disease product line with the addition of 16 new synthetic controls […]
CAMBRIDGE, UK – Nuclera, a Cambridge, UK-based biotech company developing benchtop gene and protein printing technologies, is pleased to announce that Dr Joe Keegan has been appointed to its Board as Non-executive Director. Dr Keegan has more than 30 years of experience in life science businesses. He was CEO at ForteBio Inc, a life science tool […]
EMERYVILLE, Calif. — Berkeley Lights, Inc., (Nasdaq: BLI) a leader in Digital Cell Biology, today announced the closing of its initial public offering of 9,315,000 shares of common stock, including the exercise in full by the underwriters of their option to purchase up to an additional 1,215,000 shares of common stock, at a public offering […]
Expanding research tools to detect small non-coding RNAs in situ by combining molecular information with spatial context. MINNEAPOLIS — Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the RNAscope™ platform with the release of the miRNAscope™ Assay. The RNAscope technology is an advanced in situ hybridization assay for the spatial visualization of single-molecule RNA with […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
